Abstract
Chronic kidney disease (CKD) remains a major health threat worldwide which is associated with elevated blood level of dimethylamine (DMA) and unbalanced platelet functions. Dimethylamine, a simple aliphatic amine, is abundantly found in human urine as well as other body fluids like plasma. However, the relation between dimethylamine and platelet activation is unclear. This study aims to unravel the mechanism of DMA and platelet function in chronic kidney disease. Through in vitro platelet characterization assay and in vivo CKD mouse model, the level of DMA, platelet activity and renal function were assessed by established methods. PKCδ and its downstream kinase MEK1/2 were examined by immunoblotting analysis of human platelet extract. Rescue experiments with PKCδ inhibitor or choline deficient diet were also conducted. DMA level in plasma of mouse CKD model was elevated along with enhanced platelet activation and comprised renal function. DMA can activate platelet in vitro and in vivo. Inhibition of PKCδ could antagonize the effect of DMA on platelet activation. When choline as the dietary source of DMA was deprived from CKD mouse, the level DMA was reduced and platelet activation was attenuated. Our results demonstrate that dimethylamine could enhance platelet activation in CKD model, potentially through activation of PKCδ.
Similar content being viewed by others
Data availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
References
Allen N, Barrett TJ, Guo Y, Nardi M, Ramkhelawon B, Rockman CB, Hochman JS, Berger JS (2019) Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease. Atherosclerosis 282:11–18
Anfossi G, Russo I, Doronzo G, Pomero A, Trovati M (2010) Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm 2010:174341
Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW (2011) Colonic contribution to uremic solutes. J Am Soc Nephrol 22(9):1769–1776
Asatoor AM, Simenhoff ML (1965) The origin of urinary dimethylamine. Biochim Biophys Acta 111(2):384–392
Baba S, Watanabe Y (1988) Fecal methylamine and dimethylamine in chronic renal failure. Anal Biochem 175(1):252–257
Baber U, Mehran R, Kirtane AJ, Gurbel PA, Christodoulidis G, Maehara A, Witzenbichler B, Weisz G, Rinaldi MJ, Metzger DC, Henry TD, Cox DA et al (2015) Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the assessment of dual antiplatelet therapy with drug-eluting stents registry. Circ Cardiovasc Interv 8(6):e001683
Balla S, Nusair MB, Alpert MA (2013) Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin Pharmacol 13(2):192–199
Brunnemann KD, Hecht SS, Hoffmann D (1982) N-nitrosamines: environmental occurrence, in vivo formation and metabolism. J Toxicol Clin Toxicol 19(6–7):661–688
Buensuceso CS, Obergfell A, Soriani A, Eto K, Kiosses WB, Arias-Salgado EG, Kawakami T, Shattil SJ (2005) Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta. J Biol Chem 280(1):644–653
Chen TK, Knicely DH, Grams ME (2019) Chronic kidney disease diagnosis and management: a review. JAMA 322(13):1294–1304
Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A, European Uremic Toxin Work, G. (2012) Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23(7):1258–1270
Fennema D, Phillips IR, Shephard EA (2016) Trimethylamine and trimethylamine N-Oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease. Drug Metab Dispos 44(11):1839–1850
Freedman JE, Loscalzo J (2002) Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation 105(18):2130–2132
Harper MT, Poole AW (2010) Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 8(3):454–462
Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD (2016) Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One 11(7):e0158765
Hofmann F (2018) PKC and calcium channel trafficking. Channels (Austin) 12(1):15–16
Hsu CN, Chang-Chien GP, Lin S, Hou CY, Lu PC, Tain YL (2020) Association of trimethylamine, trimethylamine N-oxide, and dimethylamine with cardiovascular risk in children with chronic kidney disease. J Clin Med 9(2):336
Jung SH, Han JH, Park HS, Lee JJ, Yang SY, Kim YH, Heo KS, Myung CS (2017) Inhibition of collagen-induced platelet aggregation by the Secobutanolide Secolincomolide A from Lindera obtusiloba Blume. Front Pharmacol 8:560
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA et al (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19(5):576–585
Konopatskaya O, Gilio K, Harper MT, Zhao Y, Cosemans JM, Karim ZA, Whiteheart SW, Molkentin JD, Verkade P, Watson SP, Heemskerk JW, Poole AW (2009) PKCalpha regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 119(2):399–407
Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, Ball S, Townend JN, Baigent C (2004) Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 43(2):244–253
Lin JK, Chang HW, Lin-Shiau SY (1984) Abundance of dimethylamine in seafoods: possible implications in the incidence of human cancer. Nutr Cancer 6(3):148–159
Liverani E, Mondrinos MJ, Sun S, Kunapuli SP, Kilpatrick LE (2018) Role of Protein Kinase C-delta in regulating platelet activation and platelet-leukocyte interaction during sepsis. PLoS One 13(4):e0195379
Meyer TW, Hostetter TH (2014) Approaches to uremia. J Am Soc Nephrol 25(10):2151–2158
Mitchell SC, Zhang AQ, Noblet JM, Gillespie S, Jones N, Smith RL (1997) Metabolic disposition of [14C]-trimethylamine N-oxide in rat: variation with dose and route of administration. Xenobiotica 27(11):1187–1197
Mobarrez F, Antovic J, Egberg N, Hansson M, Jorneskog G, Hultenby K, Wallen H (2010) A multicolor flow cytometric assay for measurement of platelet-derived microparticles. Thromb Res 125(3):e110-116
Ogawa T, Kimoto M, Watanabe H, Sasaoka K (1987) Metabolism of NG, NG-and NG, N’G-dimethylarginine in rats. Arch Biochem Biophys 252(2):526–537
Pula G, Schuh K, Nakayama K, Nakayama KI, Walter U, Poole AW (2006) PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation. Blood 108(13):4035–4044
Scanlan RA (1983) Formation and occurrence of nitrosamines in food. Cancer Res 43(5 Suppl):2435s–2440s
Shattil SJ, Cunningham M, Hoxie JA (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70(1):307–315
Simenhoff ML, Saukkonen JJ, Burke JF, Schaedler RW, Vogel WH, Bovee K, Lasker N (1978) Importance of aliphatic amines in uremia. Kidney Int Suppl (8):S16–S19
Soltoff SP (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28(9):453–458
Strom AR, Olafsen JA, Larsen H (1979) Trimethylamine oxide: a terminal electron acceptor in anaerobic respiration of bacteria. J Gen Microbiol 112(2):315–320
Tang WH (2016) Trimethylamine N-Oxide as a novel therapeutic target in CKD. J Am Soc Nephrol 27(1):8–10
Teerlink T, Hennekes MW, Mulder C, Brulez HF (1997) Determination of dimethylamine in biological samples by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 691(2):269–276
Tomlinson JAP, Wheeler DC (2017) The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease. Kidney Int 92(4):809–815
Tsikas D (2020) Urinary Dimethylamine (DMA) and its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and beyond. J Clin Med 9(6):1843
Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S (1996) Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271(38):23512–23519
Vickers JD (1999) Binding of polymerizing fibrin to integrin alpha(IIb)beta(3) on chymotrypsin-treated rabbit platelets decreases phosphatidylinositol 4,5-bisphosphate and increases cytoskeletal actin. Platelets 10(4):228–237
Windahl K, Faxen Irving G, Almquist T, Liden MK, van de Luijtgaarden M, Chesnaye NC, Voskamp P, Stenvinkel P, Klinger M, Szymczak M, Torino C, Postorini M et al (2018) Prevalence and risk of protein-energy wasting assessed by subjective global assessment in older adults with advanced chronic kidney disease: results from the EQUAL study. J Ren Nutr 28(3):165–174
Wouters OJ, O’Donoghue DJ, Ritchie J, Kanavos PG, Narva AS (2015) Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol 11(8):491–502
Wu Q, Zhao Y, Zhang X, Yang X (2019) A faster and simpler UPLC-MS/MS method for the simultaneous determination of trimethylamine N-oxide, trimethylamine and dimethylamine in different types of biological samples. Food Funct 10(10):6484–6491
Yacoub D, Theoret JF, Villeneuve L, Abou-Saleh H, Mourad W, Allen BG, Merhi Y (2006) Essential role of protein kinase C delta in platelet signaling, alpha IIb beta 3 activation, and thromboxane A2 release. J Biol Chem 281(40):30024–30035
Yang K, Wang C, Nie L, Zhao X, Gu J, Guan X, Wang S, Xiao T, Xu X, He T, Xia X, Wang J et al (2015) Klotho protects against indoxyl sulphate-induced myocardial hypertrophy. J Am Soc Nephrol 26(10):2434–2446
Yu J, Zhang TT, Gao X, Xue CH, Xu J, Wang YM (2017) Fish oil affects the metabolic process of trimethylamine N-oxide precursor through trimethylamine production and flavin-containing monooxygenase activity in male C57BL/6 mice. RSC Adv (7):56655–56661
Zaid Y, Senhaji N, Darif Y, Kojok K, Oudghiri M, Naya A (2016) Distinctive roles of PKC delta isozyme in platelet function. Curr Res Transl Med 64(3):135–139
Zeisel SH, DaCosta KA, Fox JG (1985) Endogenous formation of dimethylamine. Biochem J 232(2):403–408
Zhang AQ, Mitchell SC, Barrett T, Ayesh R, Smith RL (1994) Fate of dimethylamine in man. Xenobiotica 24(4):379–387
Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, Li L, Fu X, Wu Y, Mehrabian M, Sartor RB, McIntyre TM et al (2016) Gut Microbial Metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165(1):111–124
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All of the experimental procedures were approved by the Animal Care Committee of the Second Hospital of Hebei Medical University.
Informed consent
Not applicable.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gao, Y., Zhang, J., Chen, H. et al. Dimethylamine enhances platelet hyperactivity in chronic kidney disease model. J Bioenerg Biomembr 53, 585–595 (2021). https://doi.org/10.1007/s10863-021-09913-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-021-09913-4